Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.8 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.058 | 0.8 |